Advancing CML Management Towards an Ideal Patient Journey
The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.
EP: 1.Understanding CML: Your Journey from Diagnosis to Treatment
EP: 2.Navigating CML: Tools to Empower Patients and Caregivers
EP: 3.Empowering CML Caregivers: Strategies and Support Systems
EP: 4.Starting CML Treatment: Collaborative Choices for Better Outcomes
EP: 5.Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
EP: 6.When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
EP: 7.CML Treatment: Scenarios that Necessitate Switching Therapy
EP: 8.Ensuring Informed CML Care from Diagnosis Onward
Now Viewing
EP: 9.Advancing CML Management Towards an Ideal Patient Journey
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following:
- What are the biggest unmet needs you see for CML patients today, and how do you think emerging therapies and research could address those gaps in the future?
- What excites you most about the potential advancements in CML management that may be on the horizon in the next 5 to 10 years?
- How do you envision the CML patient experience being transformed compared to today? What would an "ideal" CML journey look like for patients and their loved ones? What would be your top recommendations if you were to advise the broader healthcare system on how to better support CML patients and caregivers?
Recent Videos
Related Content
Navigating a Paradigm Shift Venetoclax Treatment Redefines Landscape of Acute Myeloid Leukemia
Muhammad Hamza Gul, MBBS, MD;Aisha Rehman Siddiqui, MBBS, MD;Farwa Zehra, MBBS;Malaika Rehmani, MBBS;Faraz Waheed, MBBS;Natasha Masood, MBBS;Maleeha Saqib, MBBS;Mahnoor Keen, MBBS, MD;Sharan Siddharth Keshetty, MD;Maham Maqsood, MBBS;Siddharth Arjun Atwal, MD;Muhammad Hamza Sikandari, MBBS;Abdul Baseer Wardak, MBBS
August 19th 2024Article
Investigators focused on the latest advances in the treatment of patients with AML, while prioritizing the use of venetoclax as it has been shown to significantly impact the course of the disease.
